So Healthcare Continues as a Lagging Sector but Biotech is Looking Better…Update-1
Update-1 9/24/25...A quiet day in biotech except for uniQure N.V.(QURE) soaring over 247% tp $47.50 on a potential gene therapy (AMT-130) cure for Huntington's Disease!. Huntington’s disease is an inherited condition in which nerve cells in the brain break down over time. The disease affects a...
Biotech Small Cap Momentum Eases…Update-1 Huge Week for Small Cap Biotech Stocks
Update-1 9/19/25. It was Huge Week for Small Cap Biotech with all major biotech tracking ETFs UP: Unfortunately traders took profits on Friday. We will review our trades over the weekend. The IWM also led the way peaking Thursday afternoon, but still up 1.95% for the week. Biotech Momentum...
Healthcare Sector is Still Lagging- Can you Beat the S&P 500 with more Biotech?…. Update-1. biotechs!
Update-1 SMID biotechs rally underway as all there of our tracking ETFs are up ARKG up 5.6% , IBB, up 1.57%, XBI up 1.345 as a broad based rally pullls many stocks to new highs. Interest rate cut is "baked in". New small cap picks are all up: CBIO, PSNL, XNCR. Personalis (PSNL) big mover: new...
Small Cap Biopharmaceutical Stocks: Interim Update-3 Focus stocks: CBIO, PSNL, XNCR.
Small Cap Biopharma Stocks: Momentum Looks Good for Gains Our bellwether ETFs for this group are: Ark Genomic Revolution (ARKG) up 3% 1m and 5% YTD; S&P SPDR Biotech( XBI) up 7.66% 1m and 3.79% YTD. Most of these picks have been screened for analyst ratings (buy or above) and adequate cash...
Large Cap Biopharmaceuticals had a Good Month
Large Cap Biopharma Stocks Did Well in August Biopharma stocks offer growth plus dividends.Standouts are ABBV, AZN and GILD. Comeback candidates for 2026: from LLY,REGN and VRTX. Risk remains from tariffs and pushback from Trump Administration policies on drug pricing. Innovation is still key...